Further investigation demonstrates a differential role of nuclear DVL1 and DVL3 in regulating tissue-specific aromatase promoters [8] and DVL1 binding to FZD7 promoters in breast cancer models [121]. The gene discussed is DVL1; the disease is breast carcinoma.